Regulation of neovascularization by S-glutathionylation via the Wnt5a/sFlt-1 pathway.
Regulation of neovascularization by S-glutathionylation via the Wnt5a/sFlt-1 pathway.
复制标题
DOI:
10.1042/bst20140213
复制
发表时间:
2014-12
影响因子:
3.9
通讯作者:
Matsui R
中科院分区:
文献类型:
--
作者:
Murdoch CE;Bachschmid MM;Matsui R
S-glutathionylation occurs when reactive oxygen or nitrogen species react with protein cysteine thiols. Glutaredoxin-1 (Glrx) is a cytosolic enzyme which enzymatically catalyzes the reduction of S-glutathionylation, conferring reversible signaling function to proteins with redox-sensitive thiols. Glrx can regulate vascular hypertrophy and inflammation by regulating activity of NF-κB and actin polymerization. VEGF-induced endothelial cell (EC) migration is inhibited by Glrx overexpression. In mice overexpressing Glrx, blood flow recovery, exercise function and capillary density were significantly attenuated after hind limb ischemia (HLI). Wnt5a and sFlt-1 were enhanced in the ischemic limb muscle and plasma respectively from Glrx TG mice. A Wnt5a-sFlt-1 pathway had been described in myeloid cells controlling retinal blood vessel development. Interestingly, a Wnt5a-sFlt-1 pathway was found also to play a role in EC to inhibit network formation. S-glutathionylation of NF-κB components inhibits its activation. Up-regulated Glrx stimulated Wnt5a-sFlt-1 pathway through enhancing NF-κB signaling. These studies show a novel role for Glrx in post-ischemic neovascularization, which could define a potential target for therapy of impaired angiogenesis in the pathological conditions including diabetes.